Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| February 12th, 2026 |
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 25th, 2028 |
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) |
National Institutes of Health |
| June 12th, 2028 |
Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 9th, 2027 |
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| April 14th, 2026 |
Drug-Free Communities (DFC) Support Program - COMPETING CONTINUATION (Year 6) |
Centers for Disease Control - NCIPC |
| April 14th, 2026 |
Drug-Free Communities (DFC) Support Program - NEW (Year 1) |
Centers for Disease Control - NCIPC |
| April 28th, 2026 |
Comprehensive Addiction and Recovery Act (CARA) |
Centers for Disease Control - NCIPC |
| May 30th, 2029 |
Limited Competition: Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) (P30 - CT Optional) |
National Institutes of Health |
| July 1st, 2028 |
Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 25th, 2026 |
Metastasis Research Network (U54 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 9th, 2026 |
Coccidioidomycosis Collaborative Research Centers (P01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 10th, 2026 |
Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) |
National Institutes of Health |
| September 24th, 2026 |
Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) |
National Institutes of Health |
| June 20th, 2029 |
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
| May 25th, 2029 |
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 16th, 2026 |
Strengthening Ghana Health Service laboratory services, diagnostic networks, and systems for a more effective, efficient, and sustainable response to HIV, TB, and other priority health threats |
Centers for Disease Control-GHC |
| July 20th, 2026 |
Sustaining life-saving HIV services in Ukraine by strengthening resilient health systems under the Ukraine Ministry of Health, Public Health Center |
Centers for Disease Control-GHC |
| June 23rd, 2026 |
Exploratory/Developmental Grants Related to the World Trade Center Health Program (R21) |
Centers for Disease Control and Prevention - ERA |
| November 3rd, 2025 |
Ryan White HIV/AIDS Program AIDS Drug Assistance Program (ADAP) Emergency Relief Fund (ERF) |
Health Resources and Services Administration |
| July 24th, 2026 |
Enhancing sustainable health information and laboratory systems and networks for quality detection, management, and monitoring to end HIV and TB as public health threats in India |
Centers for Disease Control-GHC |
|
| September 16th, 2026 |
Ending HIV and TB as public health threats through an accelerated and sustained comprehensive response in India |
Centers for Disease Control-GHC |
| August 31st, 2026 |
Improving regional capacity to respond to HIV, TB, and other global health priorities in Central America |
Centers for Disease Control-GHC |
| June 22nd, 2026 |
Strengthening tuberculosis (TB) prevention, diagnosis, treatment, and surveillance in Asia |
Centers for Disease Control-GHC |
| July 1st, 2026 |
Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases |
Centers for Disease Control - NCEZID |
| July 1st, 2026 |
Kidney, Urologic, and Hematologic Diseases - Fostering the AdvanceMent of an Interactive Learning communitY - Coordinating Center (KUH-FAMILY) (U24- Clinical Trials Not Allowed) |
National Institutes of Health |
| November 6th, 2026 |
Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) |
National Institutes of Health |
| March 5th, 2027 |
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 5th, 2029 |
Palliative Care Research Across the Lifespan: Leveraging the Palliative Care Consortium (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 30th, 2026 |
Cooperative Centers for Experimental Hematology (CCEHs) (U54- Clinical Trial Not Allowed) |
National Institutes of Health |
| December 2nd, 2025 |
Resident Opportunity and Self-Sufficiency Service Coordinator (ROSS-SC) Program - Fiscal Year 2025 |
Department of Housing and Urban Development |
| June 15th, 2028 |
INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required) |
National Institutes of Health |
| June 15th, 2028 |
INCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 15th, 2028 |
INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 17th, 2026 |
Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required) |
National Institutes of Health |
| March 10th, 2027 |
Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) |
National Institutes of Health |
| October 20th, 2025 |
Teaching Health Center Graduate Medical Education (THCGME) Program |
Health Resources and Services Administration |
| July 15th, 2026 |
Preventing global health threats by strengthening surveillance systems to accelerate outbreak detection, notification, and response |
Centers for Disease Control-GHC |
| May 25th, 2029 |
Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed) |
National Institutes of Health |
| May 26th, 2029 |
Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed) |
National Institutes of Health |
| October 1st, 2026 |
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) |
National Institutes of Health |
